Case ID	Project	Primary Site	Gender	Files	Seq	Exp	SNV	CNV	Meth	Clinical	Bio	# Mutations	# Genes	Slides
TCGA-DD-AAEI	TCGA-LIHC	Liver and intrahepatic bile ducts	Male	70	8	4	16	11	3	10	14	1	1	2
TCGA-44-A47A	TCGA-LUAD	Bronchus and lung	Female	74	7	4	16	11	3	8	20	1	1	2
TCGA-F7-A624	TCGA-HNSC	Other and unspecified parts of mouth	Male	79	9	4	18	13	3	10	16	1	1	2
TARGET-10-PATBDJ	TARGET-ALL-P2	Hematopoietic and reticuloendothelial systems	Male	32	5	2	14	4	0	4	1	1	1	0
C3N-01340	CPTAC-3	Other and ill-defined sites	Male	51	12	8	16	2	3	0	0	1	1	0
TCGA-56-8503	TCGA-LUSC	Bronchus and lung	Female	68	8	4	16	11	3	8	14	1	1	2
TARGET-10-PATLRZ	TARGET-ALL-P2	Hematopoietic and reticuloendothelial systems	Male	32	5	2	14	4	0	4	1	1	1	0
TCGA-EE-A180	TCGA-SKCM	Skin	Male	68	6	4	16	11	3	9	14	1	1	2
TCGA-21-5787	TCGA-LUSC	Bronchus and lung	Male	70	8	4	16	11	3	8	15	1	1	3
TARGET-10-PATGWP	TARGET-ALL-P2	Hematopoietic and reticuloendothelial systems	Male	32	5	2	14	4	0	4	1	2	1	0
C3L-03963	CPTAC-3	Bronchus and lung	Male	55	13	8	16	2	6	0	0	1	1	0
C3N-01171	CPTAC-3	Uterus, NOS	Female	48	11	6	16	2	3	0	0	1	1	0
TCGA-CV-7433	TCGA-HNSC	Larynx	Male	72	6	4	16	11	3	10	17	1	1	3
TCGA-CV-A6JM	TCGA-HNSC	Other and ill-defined sites in lip, oral cavity and pharynx	Male	72	8	4	16	11	3	10	16	1	1	2
TCGA-CN-6016	TCGA-HNSC	Other and unspecified parts of tongue	Male	74	8	4	16	11	3	10	17	1	1	3
TARGET-10-PASNEH	TARGET-ALL-P2	Hematopoietic and reticuloendothelial systems	Male	32	5	2	14	4	0	4	1	1	1	0
TCGA-L7-A56G	TCGA-ESCA	Esophagus	Male	74	10	4	16	11	3	9	16	1	1	2
TCGA-BR-8680	TCGA-STAD	Stomach	Male	74	10	4	16	11	3	8	17	1	1	3
TCGA-DR-A0ZM	TCGA-CESC	Cervix uteri	Female	73	8	4	16	11	3	10	17	2	1	3
2531	BEATAML1.0-COHORT	Hematopoietic and reticuloendothelial systems	Male	25	5	2	14	0	0	0	0	1	1	0
TARGET-10-PATAYT	TARGET-ALL-P2	Hematopoietic and reticuloendothelial systems	Female	32	5	2	14	4	0	4	1	3	1	0
TCGA-33-AASD	TCGA-LUSC	Bronchus and lung	Male	68	6	4	16	11	3	8	15	1	1	3
TCGA-61-2012	TCGA-OV	Ovary	Female	70	6	4	16	11	3	9	16	1	1	4
TCGA-CR-7365	TCGA-HNSC	Other and ill-defined sites in lip, oral cavity and pharynx	Male	71	8	4	16	11	3	10	15	2	1	1
TCGA-G4-6628	TCGA-COAD	Colon	Male	72	6	4	16	11	3	10	17	2	1	3
TARGET-10-PASUGC	TARGET-ALL-P2	Hematopoietic and reticuloendothelial systems	Male	32	5	2	14	4	0	4	1	1	1	0
TCGA-CV-6962	TCGA-HNSC	Larynx	Male	95	13	8	17	14	6	10	18	1	1	4
TCGA-AA-3529	TCGA-COAD	Colon	Female	84	9	4	18	19	6	9	18	1	1	4
TARGET-10-PATHRF	TARGET-ALL-P2	Hematopoietic and reticuloendothelial systems	Male	32	5	2	14	4	0	4	1	3	1	0
TARGET-10-PATZWA	TARGET-ALL-P2	Hematopoietic and reticuloendothelial systems	Female	32	5	2	14	4	0	4	1	2	1	0
TARGET-10-PARVEI	TARGET-ALL-P2	Hematopoietic and reticuloendothelial systems	Female	34	7	2	14	4	0	4	1	1	1	0
TCGA-F1-A448	TCGA-STAD	Stomach	Male	69	8	4	16	9	3	8	16	1	1	2
MP2PRT-PAPTAS	MP2PRT-ALL	Hematopoietic and reticuloendothelial systems	Male	36	7	2	16	2	0	3	0	1	1	0
C3N-03456	CPTAC-3	Other and ill-defined sites	Male	48	11	6	16	2	3	0	0	1	1	0
TCGA-XK-AAIW	TCGA-PRAD	Prostate gland	Male	68	8	4	16	11	3	8	14	4	1	2
C3L-02669	CPTAC-3	Bronchus and lung	Male	56	14	8	16	2	6	0	0	1	1	0
MMRF_2085	MMRF-COMMPASS	Hematopoietic and reticuloendothelial systems	Female	43	9	2	28	0	0	0	0	1	1	0
TARGET-30-PAPPKJ	TARGET-NBL	Adrenal gland	Male	19	2	0	14	0	0	2	1	1	1	0
C3N-03222	CPTAC-3	Bronchus and lung	Male	55	13	8	16	2	6	0	0	1	1	0
TCGA-BT-A20V	TCGA-BLCA	Bladder	Female	74	8	4	16	11	6	10	14	1	1	2
TARGET-10-PARTBP	TARGET-ALL-P2	Hematopoietic and reticuloendothelial systems	Male	32	5	2	14	4	0	4	1	2	1	0
TCGA-LN-A5U6	TCGA-ESCA	Esophagus	Male	72	8	4	16	11	3	9	16	1	1	2
TARGET-10-PASYIS	TARGET-ALL-P2	Hematopoietic and reticuloendothelial systems	Female	32	5	2	14	4	0	4	1	2	1	0
HCM-SANG-0282-C18	HCMI-CMDC	Colon	Female	62	13	4	20	6	3	1	1	1	1	0
TARGET-10-PASLAB	TARGET-ALL-P2	Hematopoietic and reticuloendothelial systems	Female	32	5	2	14	4	0	4	1	2	1	0
TCGA-DX-A8BP	TCGA-SARC	Connective, subcutaneous and other soft tissues	Male	73	8	4	16	11	3	10	16	3	1	4
TARGET-10-PATLNS	TARGET-ALL-P2	Hematopoietic and reticuloendothelial systems	Female	32	5	2	14	4	0	4	1	2	1	0
TCGA-DU-6392	TCGA-LGG	Brain	Female	72	10	4	16	11	3	8	15	8	1	3
C3N-01510	CPTAC-3	Uterus, NOS	Female	48	11	6	16	2	3	0	0	1	1	0
TCGA-CG-4465	TCGA-STAD	Stomach	Female	74	10	4	16	11	3	8	17	1	1	3
TCGA-D1-A167	TCGA-UCEC	Corpus uteri	Female	66	4	4	16	11	3	11	16	1	1	2
TCGA-CK-5916	TCGA-COAD	Colon	Female	73	8	4	16	11	3	9	17	1	1	3
TARGET-10-PATKYI	TARGET-ALL-P2	Hematopoietic and reticuloendothelial systems	Male	32	5	2	14	4	0	4	1	1	1	0
TARGET-10-PAREGZ	TARGET-ALL-P2	Hematopoietic and reticuloendothelial systems	Female	32	5	2	14	4	0	4	1	1	1	0
TARGET-10-PARFIH	TARGET-ALL-P2	Hematopoietic and reticuloendothelial systems	Male	32	5	2	14	4	0	4	1	1	1	0
TARGET-10-PATTHR	TARGET-ALL-P2	Hematopoietic and reticuloendothelial systems	Male	32	5	2	14	4	0	4	1	1	1	0
TCGA-AP-A0LM	TCGA-UCEC	Corpus uteri	Female	69	6	4	16	11	3	11	17	1	1	3
TARGET-10-PARVMR	TARGET-ALL-P2	Hematopoietic and reticuloendothelial systems	Male	32	5	2	14	4	0	4	1	1	1	0
TCGA-EO-A3L0	TCGA-UCEC	Corpus uteri	Female	74	8	4	16	11	3	11	16	1	1	2
TCGA-CM-6167	TCGA-COAD	Colon	Female	73	8	4	16	11	3	9	17	1	1	3
TARGET-10-PARJPL	TARGET-ALL-P2	Hematopoietic and reticuloendothelial systems	Male	32	5	2	14	4	0	4	1	1	1	0
TCGA-AJ-A3EK	TCGA-UCEC	Corpus uteri	Female	75	8	4	16	11	3	11	17	1	1	3
TCGA-DK-A6B2	TCGA-BLCA	Bladder	Male	74	10	4	16	11	3	11	14	1	1	2
TCGA-G4-6306	TCGA-COAD	Colon	Male	72	8	4	16	11	3	9	16	1	1	2
TCGA-D3-A1Q5	TCGA-SKCM	Skin	Male	69	8	4	16	11	3	8	14	1	1	2
TCGA-VS-A8EK	TCGA-CESC	Cervix uteri	Female	68	8	4	16	6	3	10	16	1	1	2
TARGET-10-PARSJG	TARGET-ALL-P2	Hematopoietic and reticuloendothelial systems	Male	32	5	2	14	4	0	4	1	1	1	0
TCGA-HU-A4G6	TCGA-STAD	Stomach	Male	72	10	4	16	11	3	8	16	1	1	2
TCGA-67-3774	TCGA-LUAD	Bronchus and lung	Female	91	10	4	30	11	3	8	21	1	1	3
TCGA-FG-8186	TCGA-LGG	Brain	Female	70	8	4	16	11	3	8	15	1	1	3
C3N-02274	CPTAC-3	Uterus, NOS	Female	48	11	6	16	2	3	0	0	2	1	0
TCGA-MA-AA3Y	TCGA-CESC	Cervix uteri	Female	73	8	4	16	11	3	10	16	1	1	2
TCGA-77-A5G6	TCGA-LUSC	Bronchus and lung	Male	76	9	4	18	13	3	8	14	1	1	2
TCGA-CD-A486	TCGA-STAD	Stomach	Male	72	9	4	16	11	3	8	16	1	1	2
C3L-04849	CPTAC-3	Other and ill-defined sites	Male	48	11	6	16	2	3	0	0	1	1	0
TARGET-10-PAUAZV	TARGET-ALL-P2	Hematopoietic and reticuloendothelial systems	Male	34	7	2	14	4	0	4	1	2	1	0
TARGET-10-PATDDZ	TARGET-ALL-P2	Hematopoietic and reticuloendothelial systems	Male	32	5	2	14	4	0	4	1	2	1	0
TCGA-69-7979	TCGA-LUAD	Bronchus and lung	Female	68	8	4	16	5	3	8	20	1	1	2
TCGA-CX-7085	TCGA-HNSC	Other and unspecified parts of tongue	Female	73	8	4	16	11	3	10	16	1	1	2
TCGA-BH-A18G	TCGA-BRCA	Breast	Female	72	8	4	16	11	3	11	14	1	1	2
05CO006	CPTAC-2	Colon	Female	28	6	4	14	0	0	0	0	2	1	0
TCGA-CD-8536	TCGA-STAD	Stomach	Male	72	8	4	16	11	3	8	17	1	1	3
TCGA-HT-8105	TCGA-LGG	Brain	Male	70	8	4	16	11	3	8	15	1	1	3
TCGA-CN-5363	TCGA-HNSC	Larynx	Male	76	10	4	16	11	3	10	17	1	1	3
11CO057	CPTAC-2	Colon	Male	28	6	4	14	0	0	0	0	1	1	0
TCGA-D8-A1XQ	TCGA-BRCA	Breast	Female	72	8	4	16	11	3	11	14	1	1	2
TARGET-10-PATZFF	TARGET-ALL-P2	Hematopoietic and reticuloendothelial systems	Female	32	5	2	14	4	0	4	1	1	1	0
C3N-02282	CPTAC-3	Bronchus and lung	Male	55	13	8	16	2	6	0	0	1	1	0
TCGA-62-A46R	TCGA-LUAD	Bronchus and lung	Female	74	7	4	16	11	3	8	20	1	1	2
TCGA-CV-A465	TCGA-HNSC	Other and unspecified parts of tongue	Male	73	8	4	16	11	3	10	16	1	1	2
TCGA-AJ-A3BH	TCGA-UCEC	Corpus uteri	Female	74	8	4	16	11	3	11	16	1	1	2
TCGA-CN-6994	TCGA-HNSC	Other and ill-defined sites in lip, oral cavity and pharynx	Male	76	10	4	16	11	3	10	17	1	1	3
TCGA-22-1016	TCGA-LUSC	Bronchus and lung	Male	82	9	2	30	11	3	8	15	1	1	3
TARGET-10-PATCKV	TARGET-ALL-P2	Hematopoietic and reticuloendothelial systems	Male	32	5	2	14	4	0	4	1	2	1	0
TCGA-F4-6570	TCGA-COAD	Colon	Female	73	8	4	16	11	3	9	17	1	1	3
TCGA-FG-7638	TCGA-LGG	Brain	Female	70	8	4	16	11	3	8	15	1	1	3
TCGA-Q1-A5R2	TCGA-CESC	Cervix uteri	Female	68	8	4	16	7	3	10	16	1	1	2
TCGA-22-5492	TCGA-LUSC	Bronchus and lung	Female	71	8	4	16	9	6	8	15	1	1	3
TCGA-CV-7243	TCGA-HNSC	Other and unspecified parts of tongue	Male	74	8	4	16	11	3	10	17	1	1	3
TARGET-10-PASKIC	TARGET-ALL-P2	Hematopoietic and reticuloendothelial systems	Male	32	5	2	14	4	0	4	1	1	1	0